Sonali Quantius

Has over 10 years of professional experience in Metabolic, Cardiovascular, Neuroscience and Oncology disease areas in the pharmaceutical industry and digital health start-ups based in international environments: India, Singapore, USA, Sweden, UK, and Switzerland.
In recent years has been working on a digital health platform and founded Haplomind - a company that supports women who experience perinatal depression anytime from pregnancy to the end of the first year postpartum. At the core of Haplomind is a digital platform that can be used by pregnant/postpartum women and their gynaecologists and obstetricians at the same time.
Country: Switzerland
Visit Website